Solesence Q2 revenue falls on prior-year product launch boost
Solesence Q2 revenue falls on prior-year product launch boost
Overview
US skin health solutions provider's Q2 revenue fell yr/yr due to prior-year product launch boost
Company posted Q2 net loss, reversing net income from prior year
Company completed review of historical inventory costing allocation methodologies
Outlook
Company did not provide specific financial guidance or outlook for future periods
Result Drivers
PRIOR-YEAR LAUNCH BOOST - Co said Q2 2025 revenue benefited from a one-time product launch and inventory pipeline fill
OPERATIONAL EFFICIENCY INITIATIVES - Co said it focused on operational execution and targeted efficiency initiatives in Q2
HIGHER SG&A - Selling, general and administrative expense rose to $3.7 mln from $3.0 mln yr/yr, contributing to the net loss
Company press release: ID:nGNX8G25vL
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue |
| $15.33 mln |
|
Q2 Gross Profit |
| $4.75 mln |
|
Q2 Pretax Loss |
| $158,000 |
|
Reuters Recommended Reads
Aug 19 - Estee Lauder bets on fragrances and skincare to deliver strong annual profit
Aug 19 - Coty beats quarterly revenue estimates, names former BAT finance chief as CFO
Aug 19 - Essity to buy Kenvue's feminine care business in Brazil for $284 million
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)